Actuate Therapeutics Shares Opened For Trade At $9.88/Share; IPO Priced At $8/Share On 2.8M Shares
Portfolio Pulse from Benzinga Newsdesk
Actuate Therapeutics shares opened for trade at $9.88 per share after pricing its IPO at $8 per share on 2.8 million shares.
August 13, 2024 | 2:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Actuate Therapeutics shares opened at $9.88, significantly above its IPO price of $8 per share on 2.8 million shares, indicating strong initial demand.
The opening price of $9.88, which is higher than the IPO price of $8, suggests strong initial demand and positive market sentiment towards Actuate Therapeutics. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100